These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22768449)

  • 1. Fenofibrate, a peroxisome proliferator-activated receptor alpha, improves myocardial capillary density in diabetic rats.
    Salehi E; Khazaei M
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S9-12. PubMed ID: 22768449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats.
    Salehi E; Khazaei M; Rashidi B
    Gen Physiol Biophys; 2012 Sep; 31(3):255-60. PubMed ID: 23047938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
    Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
    Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
    Zhao X; Li LY
    Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fenofibrate improves energy metabolism and attenuates isoproterenol induced acute myocardial ischemic injury in rats via PPAR alpha activation].
    Yuan J; Wu J; Han ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):847-50. PubMed ID: 19102873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
    Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
    Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
    Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting apoptosis in the heart of streptozotocin-induced diabetic rats.
    Baraka A; AbdelGawad H
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):175-81. PubMed ID: 20133494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-α Agonist Fenofibrate Ameliorates Oxidative Stress in Testicular Tissue of Diabetic Rats.
    Yaribeygi H; Mohammadi MT; Jamialahmadi T; Sahebkar A
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):93-100. PubMed ID: 32558488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone prevents capillary rarefaction in streptozotocin-diabetic rats independently of glucose control and vascular endothelial growth factor expression.
    Ashoff A; Qadri F; Eggers R; Jöhren O; Raasch W; Dendorfer A
    J Vasc Res; 2012; 49(3):260-6. PubMed ID: 22456468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
    Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
    J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
    Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
    Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes.
    Matlock HG; Qiu F; Malechka V; Zhou K; Cheng R; Benyajati S; Whelchel A; Karamichos D; Ma JX
    Diabetes; 2020 Jun; 69(6):1279-1291. PubMed ID: 32213513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
    Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary flow velocity reserve is improved by PPAR-α agonist fenofibrate in patients with hypertriglyceridemia.
    Wang G; He L; Liu J; Yu J; Feng X; Li F; Hao Y; Mao J; Hong T; Chen AF; Wang X
    Cardiovasc Ther; 2013 Jun; 31(3):161-7. PubMed ID: 22280018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
    Dhahri W; Couet J; Roussel É; Drolet MC; Arsenault M
    Life Sci; 2013 Jan; 92(1):26-34. PubMed ID: 23142240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function.
    Gray E; Ginty M; Kemp K; Scolding N; Wilkins A
    Eur J Neurosci; 2011 Apr; 33(8):1421-32. PubMed ID: 21375604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
    Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
    Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.